Pacira BioSciences (PCRX) Other Operating Expenses (2010 - 2026)

Pacira BioSciences' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 136.8% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $160.7 million (down 50.26% YoY), while the FY2025 annual figure was $207.0 million, down 47.04% from the prior year.
• Other Operating Expenses was $2.3 million for Q1 2026 at Pacira BioSciences, down from $54.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $216.4 million in Q3 2024 to a low of -$6.2 million in Q1 2025.
• Historically, Other Operating Expenses has averaged $61.4 million across 5 years, with a median of $55.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses soared 278.19% in 2024, then slumped 110.02% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $89.5 million in 2022, then declined by 28.17% to $64.3 million in 2023, then decreased by 15.65% to $54.2 million in 2024, then climbed by 0.76% to $54.6 million in 2025, then plunged by 95.83% to $2.3 million in 2026.
• The last three Other Operating Expenses figures came in at $2.3 million (Q1 2026), $54.6 million (Q4 2025), and $48.6 million (Q3 2025), per Business Quant data.